RAYMOND JAMES FINANCIAL INC

Position in NBIX — Neurocrine Biosciences Inc

CIK 720005 ST. PETERSBURG, FL

Position in NBIX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$79,239,894

-$10,314,687 QoQ

Shares Held

601,487

-4.7% QoQ

Ownership

0.598%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 84.460844540281.ToString("F0")% Shared 0.ToString("F0")% None 15.539155459718994.ToString("F0")%

Healthcare · as of Mar 31, 2026

RAYMOND JAMES FINANCIAL INC holds $784,175,724 across 37 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,166,615	$374,325,557
2	NBIX	Neurocrine Biosciences Inc This page	601,487	$79,239,894
3	HLN	Haleon plc	6,264,041	$62,703,048
4	TEVA	Teva Pharmaceutical Industries Ltd	1,816,715	$54,719,453
5	ELAN	Elanco Animal Health Inc	1,898,337	$45,427,201
6	PBH	Prestige Consumer Healthcare Inc.	556,460	$32,981,383
7	UTHR	UNITED THERAPEUTICS Corp	47,576	$28,211,615
8	VTRS	Viatris Inc	1,855,553	$25,068,518

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$79,239,894	601,487	-4.7%	Shares	Defined	2026-05-14
2025-12-31	$89,554,581	631,422	+11.4%	Shares	Defined	2026-02-18
2025-09-30	$79,586,614	566,937	-28.4%	Shares	Defined	2025-11-14
2025-06-30	$99,486,900	791,526	-0.1%	Shares	Defined	2025-08-14
2025-03-31	$87,648,507	792,482	-6.1%	Shares	Defined	2025-05-13
2024-12-31	$115,192,622	843,902	—	Shares	Defined	2025-04-23
No filing history on record for this holder in this stock.